128 related articles for article (PubMed ID: 10227733)
1. Inhibition of gastrin-stimulated cell proliferation by the CCK-B/gastrin receptor ligand CI-988.
Dethloff LA; Barr BM; Bestervelt LL
Food Chem Toxicol; 1999; 37(2-3):105-10. PubMed ID: 10227733
[TBL] [Abstract][Full Text] [Related]
2. Divergent proliferative responses to a gastrin receptor ligand in synchronized and unsynchronized rat pancreatic AR42J tumour cells.
Bestervelt L; Barr B; Dethloff L
Cell Signal; 2000 Jan; 12(1):53-61. PubMed ID: 10676848
[TBL] [Abstract][Full Text] [Related]
3. Gastric effects of the CCK-B/gastrin receptor ligand CI-988 in cynomolgus monkeys.
Dethloff LA; Patmore SJ; Tierney BM; Bestervelt LL; Zandee JC
Food Chem Toxicol; 1998 Jan; 36(1):61-71. PubMed ID: 9487364
[TBL] [Abstract][Full Text] [Related]
4. Gastric gland degeneration induced in monkeys by the CCK-B/gastrin receptor antagonist CI-988.
Dethloff LA; Robertson DG; Tierney BM; Breider MA; Bestervelt LL
Toxicol Pathol; 1997; 25(5):441-8. PubMed ID: 9323831
[TBL] [Abstract][Full Text] [Related]
5. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.
Beinborn M; Chen C; DeMeo L; McBride EW; Kopin AS
Yale J Biol Med; 1998; 71(3-4):337-46. PubMed ID: 10461364
[TBL] [Abstract][Full Text] [Related]
6. Effect of gastrin and anti-gastrin antibodies on proliferation of hepatocyte cell lines.
Caplin M; Khan K; Grimes S; Michaeli D; Savage K; Pounder R; Dhillon A
Dig Dis Sci; 2001 Jul; 46(7):1356-66. PubMed ID: 11478485
[TBL] [Abstract][Full Text] [Related]
7. Influence of gastrin on human astrocytic tumor cell proliferation.
Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
Ding XQ; Chen D; Håkanson R
Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of biologic gastrin activity of compound CI-988 in the isolated, vascularly perfused rat stomach.
Marvik R; Sandvik AK; Waldum HL
Scand J Gastroenterol; 1997 Jun; 32(6):519-22. PubMed ID: 9200280
[TBL] [Abstract][Full Text] [Related]
10. CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides.
Bläker M; Ren Y; Seshadri L; McBride EW; Beinborn M; Kopin AS
Mol Pharmacol; 2000 Aug; 58(2):399-406. PubMed ID: 10908308
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells.
Dabrowski A; Detjen KM; Logsdon CD; Williams JA
Digestion; 1997; 58(4):361-7. PubMed ID: 9324163
[TBL] [Abstract][Full Text] [Related]
12. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin.
Blackmore M; Hirst BH
Br J Cancer; 1992 Jul; 66(1):32-8. PubMed ID: 1637673
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms for the growth factor action of gastrin.
Todisco A; Takeuchi Y; Urumov A; Yamada J; Stepan VM; Yamada T
Am J Physiol; 1997 Oct; 273(4):G891-8. PubMed ID: 9357832
[TBL] [Abstract][Full Text] [Related]
15. Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.
Smith AJ; McKernan RM
Br J Pharmacol; 1999 Jan; 126(1):79-86. PubMed ID: 10051123
[TBL] [Abstract][Full Text] [Related]
16. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
[TBL] [Abstract][Full Text] [Related]
17. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy.
Caplin ME; Clarke P; Grimes S; Dhillon AP; Khan K; Savage K; Lewin J; Michaeli D; Pounder RE; Watson SA
Regul Pept; 1999 Oct; 84(1-3):81-9. PubMed ID: 10535412
[TBL] [Abstract][Full Text] [Related]
19. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
20. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
Ohlsson B; Fredäng N; Axelson J
Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
